Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure

Fertility and Sterility

Volumn 87, Issue 6, 2007, Pages 1388-1398

  Catherino, William H ^a,b   Malik, Minnie ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

9 cis retinoic acid; alcohol dehydrogenase; aldehyde dehydrogenase; all trans retinoic acid; CRABP; CRBP; CYP 26; HPLC; Leiomyoma; microarray analysis

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALITRETINOIN; BINDING PROTEIN; CELLULAR RETINOIC ACID BINDING PROTEIN 1; CELLULAR RETINOL BINDING PROTEIN 1; CYTOCHROME P450; CYTOCHROME P450 26A1; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROARRAY ANALYSIS; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UTERUS MYOMA; WESTERN BLOTTING;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MENSTRUAL CYCLE; MIDDLE AGED; MYOMETRIUM; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRETINOIN; UTERINE NEOPLASMS;

EID: 34249717950     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.093     Document Type: Article

References (54)

1. Baird D.D. Invited commentary: uterine leiomyomata-we know so little but could learn so much. Am J Epidemiol 159 (2004) 124-126
2. Rein M.S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 108S (2000) 791-793
3. Buttram V.C., and Reiter R.C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36 (1981) 433-445
4. Otubu J.A., Buttram V.C., Besch N.F., and Besch P.K. Unconjugated steroids in leiomyomas and tumor-bearing myometrium. Am J Obstet Gynecol 143 (1982) 130-133
5. Flake G.P., Andersen J., and Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111 (2003) 1037-1054
6. Leppert P.C., Baginski T., Prupas C., Catherino W.H., Pletcher S., and Segars J.H. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril 82 (2004) 1182-1187
7. Axel D.I., Frigge A., Dittmann J., Runge H., Spyridopoulos I., Riessen R., et al. All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovasc Res 49 (2001) 851-862
8. Ara C., Devirgiliis L.C., and Massimi M. Influence of retinoic acid on adhesion complexes in human hepatoma cells: a clue to its antiproliferative effects. Cell Commun Adhes 11 (2004) 13-23
9. Lotan R. Retinoids as modulators of tumor cells invasion and metastasis. Semin Cancer Biol 2 (1991) 197-208
10. Tsibris J.C., Segars J., Coppola D., Mane S., Wilbanks G.D., O'Brien W.F., et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78 (2002) 114-121
11. Catherino W., Salama A., Potlog-Nahari C., Leppert P., Tsibris J., and Segars J. Gene expression studies in leiomyomata: new direction for research. Seminars Reprod Endocrinol 22 (2004) 83-90
12. Wu X., Blanck A., Norstedt G., Sahlin L., and Flores-Morales A. Identification of genes with higher expression in human uterine leiomyomas than in corresponding myometrium. Mol Human Reprod 8 (2002) 246-254
13. Arslan A.A., Gold L.I., Mittal K., Suen T.C., Belitskaya-Levy I., Tang M.S., et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20 (2005) 852-863
14. Boettger-Tong H., and Stancel G.M. Retinoic acid inhibits estrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology 136 (1995) 2975-2983
15. Boettger-Tong H., Shipley G., Hsu C.J., and Stancel G.M. Cultured human uterine smooth muscle cells are retinoid responsive. Proc Soc Exp Biol Med 215 (1997) 59-65
16. Tsibris J.C., Porter K.B., Jazayeri A., Tzimas G., Nau H., Huang H., et al. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium. Cancer Res 59 (1999) 5737-5744
17. Gamage S.D., Bischoff E.D., Burroughs K.D., Lamph W.W., Gottardis M.M., Walker C.L., et al. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma. J Pharmacol Exp Ther 295 (2000) 677-681
18. Marill J., Idres N., Capron C.C., Nguyen E., and Chabot G.G. Retinoic acid metabolism and mechanism of action: a review. Curr Drug Metab 4 (2003) 1-10
19. Dong D., Ruuska S.E., Levinthal D.J., and Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 274 (1999) 23695-23698
20. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 19 (2005) 1418-1428
21. Liu T., Bohlken A., Kuljaca S., Lee M., Nguyen T., Smith S., et al. The retinoid anticancer signal: mechanisms of target gene regulation. Br J Cancer 93 (2005) 310-318
22. Chang Y.S., Chung J.H., Shin D.H., Chung K.Y., Kim Y.S., Chang J., et al. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium. Yonsei Med J 45 (2004) 435-442
23. Widschwendter M., Berger J., Muller H.M., Zeimet A.G., and Marth C. Epigenetic downregulation of the retinoic acid receptor-beta2 gene in breast cancer. J Mammary Gland Biol Neoplasia 6 (2001) 193-201
24. Balmer J.E., and Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 43 (2002) 1773-1808
25. Freemantle S.J., Spinella M.J., and Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22 (2003) 7305-7315
26. Taimi M., Helvig C., Wisniewski J., Ramshaw H., White J., Amad M., et al. A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 279 (2004) 77-85
27. Niles R.M. Signalling pathways in retinoid chemoprevention and treatment of cancer. Mut Res 555 (2004) 81-96
28. Camacho L.H. Clinical applications of retinoids in cancer medicine. J Biol Regul Homeost Agents 17 (2003) 98-114
29. Dragnev K.H., Petty W.J., and Dmitrovsky E. Retinoid targets in cancer therapy and chemoprevention. Cancer Biol Ther 2 (2003) S150-S156
30. Fountzilas G. Retinoids in the management of head and neck cancer. An update. J Chemother 6 (1994) 127-138
31. Paganelli G.M., Biasco G., Brandi G., Santucci R., Gizzi G., Villani V., et al. Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst 84 (1992) 47-51
32. el-Aziz M.A., Hassan H.A., Mohamed M.H., Meki A.R., Abdel-Ghaffar S.K., and Hussein M.R. The biochemical and morphological alteration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model. Int J Exp Pathol 86 (2005) 383-396
33. Kelloff G.J. Perspectives on cancer prevention research and drug development. Adv Cancer Res 278 (1999) 199-334
34. Zaroukian S., Pineault R., Gandini S., Lacroix A., and Ghadirian P. Correlation between nutritional biomarkers and breast cancer: a case-control study. Breast 14 (2005) 209-223
35. Ito Y., Wakai K., Suzuki K., Ozasa K., Watanabe Y., Seki N., et al. Lung cancer mortality and serum levels of carotenoids, retinol, tocopherols, and folic acid in men and women: a case-control study nested in the JACC Study. J Epidemiol 2 (2005) S140-S149
36. Pienta K.J., Esper P.S., Zwas F., Krzemiinski R., and Flaherty L.E. Phase II chemoprevention trial of oral fenretinide in patients at risk foradenocarcinoma of the prostrate. Am J Clin Oncol 20 (1997) 36-39
37. Gorsky M., and Epstein J.B. The effect of retinoids on premalignant oral lesions: focus on topical therapy. Cancer 95 (2002) 1258-1264
38. Lodi G., Sardella A., Bez C., Demarosi F., and Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev 6 (2004) 15-16
39. Abu J., Batuwangala M., Herbert K., and Symonds P. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. Lancet Oncol 6 (2005) 712-720
40. Lengfelder E., Saussele S., Weisser A., Buchner T., and Hehlmann R. Treatment concepts of acute promyelocytic leukemia. Crit Rev Oncol Hematol 56 (2005) 261-274
41. Decensi A., Serrano D., Bonanni B., Cazzaniga M., and Guerrieri-Gonzaga A. Breast cancer prevention trials using retinoids. J Mammary Gland Biol Neoplasia 8 (2003) 19-30
42. Shen Q., and Brown P.H. Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways. J Mammary Gland Biol Neoplasia 8 (2003) 45-73
43. Catherino W.H., Malik M., et al. Novel method to characterize primary cultures of leiomyoma and myometrium using confirmatory biomarker gene arrays. Fertil Steril (2007) in press
44. Catherino W.H., Prupas C., Tsibris J.C., Leppart P.C., Payson M., Nieman L.K., et al. Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 80 (2003) 282-290
45. Catherino W.H., Leppert P.C., Stenmark M.H., Payson M., Potlog-Nahari C., Nieman L.K., et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chrom Cancer 40 (2004) 204-217
46. Lipshutz R.J., Fodor S.P., Gingeras T.R., and Lockhart D.J. High density synthetic oligonucleotide arrays. Nat Genet 21 (1999) 20-24
47. Kane M.A., Chen N., Sparks S., and Napoli J.L. Quantification of endogenous retinoic acid in limited biological samples by LC/MS/MS. Biochem J 388 (2005) 363-369
48. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 (2001) e45
49. Napoli J.L. Biosynthesis and metabolism of retinoic acid: roles of CRBP and CRABP in retinoic acid: roles of CRBP and CRABP in retinoic acid homeostasis. J Nutr 123 (1993) 362-366
50. Van Heusden J., Wouters W., Ramaekers F.C., Krekels M.D., Dillen L., Borgers M., et al. The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells. Br J Cancer 77 (1998) 1229-1235
51. Schmitt-Graff A., Ertelt V., Allgaier H.P., Koelble K., Olschewski M., Nitschke R., et al. Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival. Hepatology 38 (2003) 470-480
52. Ozpolat B., Mehta K., Tari A.M., and Lopez-Berestein G. All-trans-retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia. Am J Hematol 70 (2002) 39-47
53. Osanai M., and Petkovich M. Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol 67 (2005) 1808-1817
54. Martel K.M., Ko A.C., Christman G.M., and Stribley J.M. Apoptosis in human uterine leiomyomas. Semin Reprod Med 22 (2004) 91-103